PHIA Koninklijke Philips N.V.

Philips launches pre-hospital wireless monitoring solution for emergency medical response in U.S.

Philips launches pre-hospital wireless monitoring solution for emergency medical response in U.S.

July 29, 2020

  • Philips receives 510(k) clearance from the FDA for its professional defibrillator (Tempus LS- Manual), now offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U.S.
  • Solution delivers real-time bidirectional data transfer for remote patient monitoring, giving EMS responders a new approach to pre-hospital care

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the U.S. The solution is a complete end-to-end system that combines innovative hardware and advanced software to expand the pre-hospital scope of care for first responders. The professional defibrillator (Tempus LS-Manual) is the final element of the overall solution to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale in the U.S. market.

As a unique modular platform, the (Tempus ALS) consists of a remote portable vital signs patient monitor (Tempus Pro), and remote professional defibrillator (Tempus LS-Manual). While the monitor and defibrillator can be used separately, the devices also connect wirelessly to share data and transfer vitals, waveforms and images into Philips web-based software platform (IntelliSpace Corsium). The software platform provides robust, real-time transfer of clinical data and events, interactive ECG measurement, two-way communication and more, enabling rapid clinical and transport decision support and seamless electronic patient care recording (ePCR) integration outside the hospital in emergency settings.

“In emergency situations, where seconds count, having access to advanced patient data collection and sharing and real-time secure data streaming, can help inform confident treatment and transport decisions outside the hospital,” said Arman Voskerchyan, General Manager of Therapeutic Care at Philips. “The integrated remote monitoring and defibrillator solution combined with our web-based software platform will help front line responders provide emergency care, diagnosis and treatment - including defibrillation therapy, data management and clinical and operational efficiency features – in a fully integrated solution.”

Emergencies and care events outside the hospital continue to rise, with an estimated 240 million calls made to 9-1-1 in the U.S. each year [1]. In addition to the stress of the unknown and what to expect at the scene of the call, emergency medical providers must deal with manual handling issues. Equipment carried is heavy, often damaged due to use in unpredictable conditions and has limited data connectivity – inhibiting the ability for on-scene support. In an effort to address these challenges, both elements of the Philips remote monitoring and defibrillator (Tempus ALS) solution are designed with a small, rugged exterior and long-lasting battery to allow emergency medical providers to focus on caring for the patient without the hassle or distraction of bulky equipment.

Philips leadership in Emergency Care solutions

Earlier this year, Philips launched its new in the U.S. market, previously in use in Europe, helping care teams spot life-threatening conditions remotely, improve accuracy of support from on-scene crews, and enhance tailoring of in-hospital care based on pre-hospital physiology. In October 2019, Philips  where helicopter Emergency Service (HEMS) teams were able to live stream patient medical information from the scene to the hospital through the Philips pre-hospital solution. Philips offers a wide range of emergency care offerings, including automated external defibrillators (AEDs), advanced life support monitors, and more. Visit for more information on the remote monitoring and defibrillator solution and Philips broad portfolio of Emergency Care solutions.

[1]

For further information, please contact:

Kathy O'Reilly 

Philips Global Press Office

Tel:

E-mail : 

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



 

Attachments

EN
29/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2024

Philips convenes the Annual General Meeting of Shareholders 2024  March 22, 2024 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959) and Peter Löscher (Austrian, 1957) as members of the Supervisory Board, with effect from May 7, 2024.Proposal to appo...

 PRESS RELEASE

Leading in health technology innovation: Philips one of the top patent...

Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office March 19, 2024   Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation, Philips’ extensive global R&D programs and collaborations position the company at the forefront of health technology innovation. In 2023, Philips improved the health and well-being of 1.9 billion people with its innovations. Wi...

 PRESS RELEASE

Philips and AWS collaborate to scale digital pathology in the cloud, e...

Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity March 12, 2024 Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaborationCollaboration combines best of clinical workflow leadership with scalable cloud solution to help accelerate decision-making and further transform patient care Amsterdam, the Netherlands and Orlando, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with ...

Marc Hesselink ... (+3)
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Philips/More clarity needed/HOLD

Philips' underlying performance in 4Q23 was a bit weaker than we expected mainly because of the margin in D&T. Next to that the consent decree with the FDA, although more punitive than we expected, was another milestone to pass in the ongoing Respironics recall. Key uncertainty remains the litigation process which in our view remains a black-box overhang on the investment case. We have small downward revisions to our estimates (mainly on currencies). We reiterate our €19 per share target price a...

 PRESS RELEASE

Health technology leader Philips recognized as Clarivate Top 100 Globa...

Health technology leader Philips recognized as Clarivate Top 100 Global Innovator March 6, 2024 Company’s innovative products and solutions improved the lives of 1.9 billion people in 2023 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been included in the . Philips’ global R&D programs and collaborations aim to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Together with healthcare providers and other ecosystem partners, Phi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch